1.
Gangat N, Bellam N, Reichard K, Tefferi A. Emergence of <i>TP53</i&gt; mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine. Haematologica 2024;109(4):1306-1309; https://doi.org/10.3324/haematol.2023.284547.